ORIGINAL RESEARCH
Accepted on 26 Aug 2025
SRC Is a Potential Target of Arctigenin in Treating Triple-Negative Breast Cancer: Based on Machine Learning Algorithms, Molecular Modeling and in Vitro Test
doi 10.3389/fmolb.2025.1644169
507
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.